| Isobel A. Scarisbrick, Lincoln I. Wurtz |
Assessing and Treating Multiple Sclerosis |
U.S. Provisional Patent 63/548,346 |
2023 |
| Isobel A. Scarisbrick, Hyesook Yoon, Kristen Drucker, Chanil Choi |
PAR1 Modulation to Alter Myelination |
U.S. Patent 17/528,103 |
2023 |
| Isobel A. Scarisbrick, Erin M. Triplet |
Targeting PAR1 and PAR2 To Regulate Lipid and Cholesterol Abundance |
U.S. National Application 17/792,591 |
2022 |
| Isobel A. Scarisbrick, Erin M. Triplet |
Targeting PAR1 and PAR2 To Regulate Lipid and Cholesterol Abundance |
European Patent National Application 21741025.7 Pending |
2021 |
| Isobel A. Scarisbrick, Hyesook Yoon |
PAR1 Modulation To Alter Myelination |
U.S. Continuation Application 17/528,566 |
2021 |
| Isobel A. Scarisbrick, Erin M. Triplet |
Targeting PAR1 or PAR2 To Regulate Lipid Abundance |
U.S. Patent Application 62/960,881 |
2020 |
| Isobel A. Scarisbrick |
Methods and Materials for Modulating Resistance to Apoptosis Using KLK6 Antisense and miRNA Molecules |
U.S. Patent 10/279,037B2 |
2019 |
| Isobel A. Scarisbrick |
KLK6 as a Therapeutic Target To Alter Cell Survival (Notice of Allowance Received) |
U.S. Patent 15/584,822 Pending |
2019 |
| Isobel A. Scarisbrick |
Methods for Increasing Susceptibility to Apoptosis by Administering an Inhibitor of Kallikrein 6 Polypeptide Activity Notice of Allowance Received |
U.S. Patent 9,669,094 |
2017 |
| Isobel A. Scarisbrick, Hyesook Yoon |
PAR2 Modulation To Alter Myelination |
U.S. Patent 17/944,699 Pending |
2017 |
| Isobel A. Scarisbrick, Hyesook Yoon, Kristen Drucker |
Protease-Activated Receptor 1 Modulation To Alter Myelination |
U.S. Patent Continuation Application 17/528,566 |
2015 |
| Isobel A. Scarisbrick |
Methods for Modulating Resistance to Apoptosis using KLK6 |
U.S. Patent 8,530,427 |
2013 |
| Isobel A. Scarisbrick, Moses Rodriguez, Sachiko Blaber, Michael Blaber |
Method of Treating Multiple Sclerosis With Anti-K6 Antibody |
U.S. Patent 7,754,216 |
2010 |
| Isobel A. Scarisbrick, Moses Rodriguez, Sachiko Blaber, Michael Blaber |
Methods and Materials for Treating and Diagnosing Kallikrein-6 Related Inflammatory Conditions |
European Patent 1513553 B1 |
2009 |
| Isobel A. Scarisbrick, Moses Rodriguez, Sachiko Blaber, Michael Blaber |
Methods and Materials for Treating Inflammatory Conditions |
European Patent 03734121.1 |
2003 |